Effect of recombinant human keratinocyte growth factor in inducing Ras-Raf-Erk pathway-mediated cell proliferation in emphysematous mice lung

Inhalation Toxicology

Volumn 26, Issue 13, 2014, Pages 761-771

  Muyal, Jai Prakash ^a   Kotnala, Sudhir ^a   Bhardwaj, Harsh ^a   Tyagi, Amit ^b  

^a GAUTAM BUDDHA UNIVERSITY   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Alveolar regeneration; Emphysema; Ras Raf Erk pathway; RHuKGF

Indexed keywords

COMPLEMENTARY DNA; CYCLINE; ELASTASE; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PALIFERMIN; RAF PROTEIN; RAS PROTEIN; FGF7 PROTEIN, HUMAN; FGFR2 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR RECEPTOR 2; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DESTRUCTIVE INDEX; DRUG EFFECT; GENE EXPRESSION; HISTOPATHOLOGY; INVESTIGATIVE PROCEDURES; LIMIT OF QUANTITATION; LUNG ALVEOLUS EPITHELIUM; LUNG EMPHYSEMA; LUNG PARENCHYMA; MALE; MICROPHOTOGRAPHY; MORPHOMETRICS; MOUSE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONHUMAN; ONCOGENE C MYC; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE REGENERATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; HUMAN; LUNG; LUNG ALVEOLUS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY EMPHYSEMA;

MUS;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 7; HUMANS; LUNG; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; PULMONARY ALVEOLI; PULMONARY EMPHYSEMA; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECOMBINANT PROTEINS;

EID: 84908599842     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2014.957426     Document Type: Article

References (64)

1. Avruch J, Zhang XF, Kyriakis JM. (1994). Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem Sci 19: 279-83.
2. Beer HD, Gassmann MG, Munz B, et al. (2000). Expression and function of keratinocyte growth factor and activin in skin morphogenesis and cutaneous wound repair. J Investig Dermatol Symp Proc 5: 34-9.
3. Behrens P, Rothe M, Wellmann A, et al. (2001). The Ets-1 transcription factor is upregulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194: 43-50.
4. Bravo R, Macdonald-Bravo H. (1987). Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 105: 1549-54.
5. Buckley S, Driscoll B, Barsky L, et al. (1999). ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am J Physiol 277: L159-66.
6. Celis JE, Madsen P, Celis A, et al. (1987). Cyclin (PCNA, auxiliary protein of DNA polymerase delta) is a central component of the pathway(s) leading to DNA replication and cell division. FEBS Lett 220: 1-7.
7. Celis JE, Celis A. (1985). Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci 82: 3262-6.
8. Celis JE, Madsen P. (1986). Increased nuclear cyclin/PCNA antigen staining of non S-phase transformed human amnion cells engaged in nucleotide excision DNA repair. FEBS Lett 209: 277-83.
9. Waters CM, Savla U. (1999). Keratinocyte growth factor accelerates wound closure in airway epithelium during cyclic mechanical strain. J Cell Physiol 181: 424-32.
10. Cleveland JL, Troppmair J, Packham G, et al. (1994). v-Raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene 9: 2217-26.
11. Deak M, Clifton AD, Lucocq LM, Alessi DR. (1998). Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17: 4426-41.
12. Deterding RR, Havill AM, Yano T, et al. (1997). Prevention of bleomycin induced lung injury in rats by keratinocyte growth factor. Proc Assoc Am Physicians 109: 254-68.
13. Erhardt P, Schremser EJ, Cooper GM. (1999). B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol Cell Biol 19: 5308-15.
14. Facchini LM, Penn LZ. (1998). The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J 12: 633-51.
15. Hamzaoui H, Rizk RM, Gordon J, et al. (2007). PTHrP P3 promoter activity in breast cancer cell lines: role of Ets1 and CBP (CREB binding protein). Mol Cell Endocrinol 268: 75-84.
16. Henriksson M, Luscher B. (1996). Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 68: 109-82.
17. Hideaki N, Robert V, Gillian M. (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-73.
18. Hogg JC. (1997). A stimulating treatment for emphysema. Nat Med 3: 603-5.
19. Hurd S. (2000). The impact of COPD in lung health worldwide: epidemiology and incidence. Chest 117: 1S-4S.
20. Schlosser I, Hölzel M, Mürnseer M, et al. (2003). A role for c-Myc in the regulation of ribosomal RNA processing. Nucleic Acids Res 3: 6148-56.
21. Jaskulski D, De Riel JK, Mercer WE, et al. (1988). Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science 240: 1544-6.
22. Jelinek T, Dent P, Sturgill TW, Weber MJ. (1996). Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation. Mol Cell Biol 16: 1027-34.
23. Dong J, Sutor S, Jiang G, et al. (2011). c-Myc regulates self-renewal in bronchoalveolar stem cells. PLoS One 6: e23707.
24. Kim WD, Eidelman DH, Izquierdo JL, et al. (1991). Centrilobular and panlobular emphysema in smokers. Am Rev Respir Dis 144: 1385-90.
25. Le Gall M, Chambard JC, Breittmayer JP, et al. (2000). The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol Biol Cell 11: 1103-12.
26. Lemaitre JM, Buckle RS, Mechali M. (1996). c-Myc in the control of cell proliferation and embryonic development. Adv Cancer Res 70: 95-144.
27. Liang Q, Mohan RR, Chen L, Wilson SE. (1998). Signaling by HGF and KGF in corneal epithelial cells: Ras/MAP kinase and Jak-STAT pathways. Invest Ophthalmol Vis Sci 39: 1329-38.
28. Lin AW, Barradas M, Stone JC, et al. (1998). Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12: 3008-19.
29. Liu YC, Marraccino RL, Keng PC, et al. (1989). Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle. Biochemistry 28: 2967-74.
30. Marais R, Wynne J, Treisman R. (1993). The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73: 381-93.
31. Massaro D, Massaro GD. (2006). Toward therapeutic pulmonary alveolar regeneration in humans. Proc Am Thorac Soc 3: 709-12.
32. McElroy MC, Kasper M. (2004). The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair. Eur Respir J 24: 664-73.
33. Min D, Taylor PA, Panoskaltsis-Mortari A, et al. (2002). Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99: 4592-600.
34. Muyal V. (2010). Therapeutic effects of recombinant human keratinocyte growth factor (rHuKGF) in an elastase-induced emphysema model in the mouse [dissertation for the doctoral degree of human biology]. Germany: University of Marburg, The Department of Medicine.
35. Muyal JP, Muyal V, Kaistha BP, et al. (2009). Systematic comparison of RNA extraction techniques from frozen and fresh lung tissues: checkpoint towards gene expression studies. Diagn Pathol 4: 9. doi: 10.1186/1746-1596-4-9.
36. Muyal JP, Muyal V, Kotnala S, et al. (2013). Therapeutic potential of growth factors in pulmonary emphysematous condition. Lung 191: 147-63.
37. Nelson KK, Melendez JA. (2004). Mitochondrial redox control of matrix metalloproteinases. Free Radical Biol Med 37: 768-84.
38. Brigitte NG, John AB, Michael CF, et al. (2007). Keratinocyte growth factor improves repair in the injured tracheal epithelium. Am J Respir Cell Mol Biol 37: 48-56.
39. Palmieri C, Roberts-Clark D, Assadi-Sabet A, et al. (2003). Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1betainduced paracrine growth factor for human breast cells. J Endocrinol 177: 65-81.
40. Plantier L, Marchand-Adam S, Antico Arciuch VG, et al. (2007). Keratinocyte growth factor protects against elastase-induced pulmonary emphysema in mice. Am J Physiol Lung Cell Mol Physiol 293: L1230-9.
41. Portnoy J, Curran-Everett D, Mason RJ. (2004). Keratinocyte growth factor stimulates alveolar type II cell proliferation through the extracellular signal-regulated kinase and phosphatidylinositol 3-OH kinase pathways. Am J Respir Cell Mol Biol 30: 901-7.
42. Prokhorova S, Patel N, Laskin DL. (1998). Regulation of alveolar macrophage and type II cell DNA synthesis: effects of ozone inhalation. Am J Physiol 275: L1200-7.
43. Rabe KF, Hurd S, Anzueto A, et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-55.
44. Rajalingam K, Wunder C, Brinkmann V, et al. (2005). Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat Cell Biol 7: 837-43.
45. Robbesom AA, Versteeg EM, Veerkamp JH, et al. (2003). Morphological quantification of emphysema in small human lung specimens: comparison of methods and relation with clinical data. Mod Pathol 16: 1-7.
46. Saetta M, Shiner RJ, Angus GE, et al. (1985). Destructive Index: a measurement of lung parenchymal destruction in smokers. Am Rev Respir Dis 131: 764-9.
47. Savla U, Waters CM. (1998). Barrier function of airway epithelium: effects of radiation and protection by keratinocyte growth factor. Radiat Res 150: 195-203.
48. Seifart C, Muyal JP, Plagens A, et al. (2011). All-trans retinoic acid results in irregular repair of septa and fails to inhibit proinflammatory macrophages. Eur Respir J 38: 425-39.
49. Sotozono C, Inatomi T, Nakamura M, Kinoshita S. (1995). Keratinocyte growth factor accelerates corneal epithelial wound healing in vivo. Invest Ophthalmol Vis Sci 36: 1524-9.
50. Spencer CA, Groudine M. (1991). Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res 56: 1-48.
51. Staiano-Coico L, Krueger JG, Rubin JS, et al. (1993). Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J Exp Med 178: 865-78.
52. Takeoka M, Ward WF, Pollack N, et al. (1997). Keratinocyte growth factor facilitates repair of radiation-induced DNA damage in alveolar epithelial cells. Am J Physiol 272: L1174-80.
53. Taraseviciene-Stewart L, Voelkel NF. (2008). Molecular pathogenesis of emphysema. J Clin Invest 118: 394-402.
54. Ulich TR, Yi ES, Longmuir K, et al. (1994). Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest 93: 1298-306.
55. Utz JP, Hubmayr RD, Deschamps C. (1998). Lung volume reduction surgery for emphysema: out on a limb without a NETT. Mayo Clin Proc 73: 552-66.
56. Ware LB, Matthay MA. (2002). Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation and repair. Am J Physiol 282: L924-40.
57. Werner S. (1998). Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 9: 153-65.
58. Wilson SE, Walker JW, Chwang EL, He YG. (1993). Hepatocyte growth factor, keratinocyte growth factor, their receptors, fibroblast growth factor receptor-2, and the cells of the cornea. Invest Ophthalmol Vis Sci 34: 2544-61.
59. Woods D, Parry D, Cherwinski H, et al. (1997). Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 17: 5598-611.
60. 2 exposure. Am J Physiol 275: L780-7.
61. Xia Z, Dickens M, Raingeaud J, et al. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-31.
62. Yano T, Deterding RR, Simonet WS, et al. (1996). Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am J Respir Cell Mol Biol 15: 433-42.
63. Yildirim AO, Muyal V, John G, et al. (2010). Palifermin induces alveolar maintenance programs in emphysematous mice. Am J Respir Crit Care Med 181: 705-17.
64. Zeeh JM, Procaccino F, Hoffmann P, et al. (1996). Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 110: 1077-83.